Christopher Lloyd
About Christopher Lloyd
Christopher Lloyd serves as the Financial Controller at Flow Pharma, Inc. in Madrid, Spain, where he has worked since 2015, contributing to advancements in drug delivery platforms and therapies.
Work at Flow Pharma
Christopher Lloyd has served as the Financial Controller at Flow Pharma, Inc. since 2015. His tenure spans nine years in Madrid, Spain. In this role, he has contributed to the financial management and strategic oversight of the company. His involvement includes significant contributions to the development of synthetic dry powder drug discovery, which offers the advantage of not requiring refrigeration. Additionally, he has played a role in the issuance of several patents related to peptide formulation and microsphere drug delivery platforms.
Work at Safeinhome
Since 2015, Christopher Lloyd has also held the position of Financial Controller at Safeinhome. His responsibilities include overseeing financial operations and ensuring compliance with financial regulations. His dual role at both Flow Pharma and Safeinhome highlights his expertise in financial management within the pharmaceutical and healthcare sectors.
Education and Expertise
Christopher Lloyd earned a Bachelor's degree in Marketing from the University of Oregon. His educational background provides a foundation for his expertise in financial management and strategic planning, particularly in the pharmaceutical industry. His academic training supports his ability to navigate complex financial landscapes effectively.
Previous Experience
Prior to his current roles, Christopher Lloyd worked at Security Research Associates as an Investments professional from 2013 to 2016 in San Francisco, California. He also served as a Senior Mortgage Loan Officer at Banc of California for six months in 2016 in Santa Ana, California. These positions contributed to his diverse experience in finance and investment.
Contributions to Healthcare Solutions
Christopher Lloyd has been involved in uncovering solutions for virus and cancer therapies that can be customized for individual patients or applied on a larger scale. His work at Flow Pharma has focused on innovative drug delivery systems and therapeutic solutions, emphasizing his commitment to advancing healthcare through financial oversight and strategic development.